German biotech company Evotec said on Monday it had received a grant from the Bill & Melinda Gates Foundation to help identify and develop potential monoclonal antibody (mAbS) drugs for the prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback